Despite shutdown, companies still plan to submit upcoming FDA applicationsnews2025-10-02T15:21:14+00:00October 2nd, 2025|Endpoints News|
Roche was the only pharma to make an acquisition offer for 89bionews2025-10-02T12:41:57+00:00October 2nd, 2025|Endpoints News|
Exclusive: Upcoming ACIP meeting may move to Decembernews2025-10-01T21:25:13+00:00October 1st, 2025|Endpoints News|
Third-round IRA guidance spells out new orphan drug protectionsnews2025-10-01T20:00:21+00:00October 1st, 2025|Endpoints News|
Pfizer-White House deal prompts pharma rally on Wall Streetnews2025-10-01T19:48:48+00:00October 1st, 2025|Endpoints News|
Biogen owes Genentech $88M in royalties from Tysabri, court rulesnews2025-10-01T19:24:10+00:00October 1st, 2025|Endpoints News|
Trump’s 100% pharma tariff won’t start Oct. 1, White House confirmsnews2025-10-01T18:04:52+00:00October 1st, 2025|Endpoints News|
Post-Hoc Live: Unpacking Trump and Pfizer’s ‘most favored nation’ dealnews2025-10-01T13:34:35+00:00October 1st, 2025|Endpoints News|
What we do and don’t know after the White House’s deal with Pfizernews2025-09-30T21:12:54+00:00September 30th, 2025|Endpoints News|
FDA approves Novartis’ BTK inhibitor for chronic hivesnews2025-09-30T20:57:00+00:00September 30th, 2025|Endpoints News|
